Catalogue description Department of Health: Health Services Human Growth Hormone Committee: Health Services Pituitary Collection and Distribution Committee: Registered Files

Search within or browse this series to find specific records of interest.

Date range

Details of JA 260
Reference: JA 260
Title: Department of Health: Health Services Human Growth Hormone Committee: Health Services Pituitary Collection and Distribution Committee: Registered Files
Description:

This series contains files relating to the Secretary of State's licences for the development of Human Growth Hormone products, The Health Services Human Growth Hormone Committee, The National Institute for Biological Standards and Control (NIBSC), The Steering Committee for Human Pituitary Collection and other general human growth hormone matters
Date: 1974-2006
Held by: The National Archives, Kew
Former reference in its original department: APH, GED, PKL, PVR and SER file series
Legal status: Public Record(s)
Language: English
Creator:

Department of Health, 1988-

Department of Health and Social Security, 1968-1988
Physical description: 225 file(s)
Access conditions: Open unless otherwise stated
Immediate source of acquisition:

From 2018 Department of Health
Custodial history: Prefix was first issued from Central File Records to File Office 172, Office of the Chief Pharmacist in 1991 to replace the old file abbreviations APPP (Appliances) and DISP (Dispensing). Prefix was still in use by branch in 1999. Recorded as transferred to File Office 98 in 2004 when the title was changed from Pharmaceutical Matters to Office of Chief Pharmacist. Recorded on the Central File Registry as closed in 2007.
Selection and destruction information: The majority of the pharmaceutical product licence files have not been selected.
Accruals: Series is accruing
Administrative / biographical background:

There was a major legal case in 1996 surrounding the use of Human Growth Hormone (HGH) and subsequent development of Creutzfeld-Jakob Disease (CJD) in a number of patients treated with it. HGH is now created synthetically but initially it had been 'harvested' from the pituitary glands of cadavers in mortuaries and it was alleged that contaminated products were created through the collection of glands from some patients who may have died from brain diseases.

Have you found an error with this catalogue description?

Help with your research